ARGS快了# Stock
g*e
1 楼
DURHAM, N.C., Nov. 12, 2014 (GLOBE NEWSWIRE) -- Argos Therapeutics, Inc. (
Nasdaq:ARGS), a biopharmaceutical company focused on the development and
commercialization of fully personalized immunotherapies for the treatment of
cancer and infectious diseases using its Arcelis® technology platform,
today announced that Jeff Abbey, president and chief executive officer,
will present at the Stifel 2014 Healthcare Conference on Tuesday, November
18th, 2014 at 3:00 p.m. Eastern Time. Mr. Abbey will provide an update of
the AGS-003 clinical development program, including the ADAPT trial, as well
as the AGS-004 program. The conference will be held at The New York Palace
Hotel, in New York, NY.
明天盘后ER,二期结果要么明天，要么十一月18号.
我有少量，风险回报都大。小心！
Nasdaq:ARGS), a biopharmaceutical company focused on the development and
commercialization of fully personalized immunotherapies for the treatment of
cancer and infectious diseases using its Arcelis® technology platform,
today announced that Jeff Abbey, president and chief executive officer,
will present at the Stifel 2014 Healthcare Conference on Tuesday, November
18th, 2014 at 3:00 p.m. Eastern Time. Mr. Abbey will provide an update of
the AGS-003 clinical development program, including the ADAPT trial, as well
as the AGS-004 program. The conference will be held at The New York Palace
Hotel, in New York, NY.
明天盘后ER,二期结果要么明天，要么十一月18号.
我有少量，风险回报都大。小心！